MONOCLONAL ANTIBODY TREATMENT
THE IMPORTANCE OF ACTING IMMEDIATELY AFTER A COVID POSITIVE TEST
After launching a public awareness campaign, and great efforts to make monoclonal antibody treatments available locally, over 125 high risk people who are COVID positive in our community have been successfully treated and some likely avoided hospitalization. There have been others in our community that chose to wait after learning they tested positive because “they were not feeling too badly” or “wanted to wait and see how they will feel in a few days” and are in a more serious condition today as they did not take the antibodies. We must get the word out clearly that if you fit the criteria in the accompanying letter for receiving this treatment you MUST NOT WAIT after getting a positive Covid test--even if you are feeling fine. This treatment has thus far demonstrated to be very effective but MUST be administered right after a Covid positive test--whether or not you have any symptoms. If you are in ANY of the high risk categories listed in the antibody criteria you must contact one of your Doctors or Patient Advocates ASAP in order to efficiently be guided through the process.
This treatment is not a cure and should not be thought of as an alternative to protecting yourself from getting infected in the first place. Continue to take all measures to avoid infection including masking, avoiding gatherings, continue social distancing and hand washing. If you, nonetheless, contract Covid you should ACT IMMEDIATELY by following the guidance on the accompanying letter in conjunction with your Doctor’s advice. Monoclonal Antibody treatment is allowed to be given under an Emergency Use Authorization (EUA) granted by the FDA only in the first few days after diagnosis and is proving, so far, to be very effective. After that early window closes, its use is no longer allowed since it is not effective, and you will not be able to receive it.
This therapy is outpatient, the side effects in the experience of the medical centers are minimal if any, and the treatment is standardized; so it can be accessed wherever is easiest and fastest to get an appointment.
If you test COVID positive and meet the criteria below, it is urgent that you obtain an antibody infusion as soon as possible after your positive test.
Please contact one of the community patient advocates listed in this memo if you meet the FDA criteria outlined below so that they can work with your doctor and schedule you for the outpatient infusion.
Our community patient advocates are keeping tabs on where the antibodies are available and how best to schedule you in for a slot. The infusion process is short and you should be back home in a few hours.
It is best to get these antibodies as soon as possible after receiving a COVID positive PCR test result. Once you receive the antibodies, please continue to practice social distancing and masking as you can still spread the virus to others.
If you are not currently infected, please continue to avoid getting infected with COVID; It is critical to implement proper distancing, masking, etc. There is no guarantee that any particular treatment will help an individual. This is a challenging period as many people in the community have been infected. Keep yourself and your family safe.
If you receive the antibody treatment, you should wait 90 days and consult with your doctor before getting vaccinated.
Dr. Albert Bassoul, MD
Alan Esses, Hatzalah
Dr. Albert Ftiha, MD
Dr. Victor Grazi, MD, Mt Sinai
Dr. David Khaski, MD, NYU
Dr. Ralph Madeb, MD, NYCH
Dr. Daniel Matalon, MD, NYU
Dr. Stanley Schrem, MD, NYU
Gershon Fink, MD
Dr. Ralph Madeb
Ike D Massry
Dr. Ralph Madeb
Medical Centers offering Monoclonal Antibodies for Outpatient Infusion
Monmouth Medical Center
New York Community Hospital
Mt Sinai of Miami Beach
FDA Inclusion Criteria
The antibody treatments are for high risk patients. High risk is defined as patients who meet at least one of the following criteria:
65 years of age or older
Adult who is obese or has a BMI greater than 25
Child who has a BMI greater than 85th percentile
Patient who has cancer or are in remission of cancer
Pregnant or 12 weeks postpartum
Chronic kidney or lung disease including asthma
Diabetes, High blood pressure & any cardiovascular diseases
Sickle cell disease
Immunocompromised or taking immunocompromising medication
Medical-related technological dependence such as tracheostomy or gastrostomy
This communication is provided for informational purposes only and does not constitute the provision of medical advice. The information is being made available in the context of the public health emergency related to COVID-19, has been obtained from publicly available sources, and has not been subjected to review or investigation that typically would be performed in a non-emergent situation. This information is not meant to be complete, exhaustive, or a substitute for medical professional advice, diagnosis, or treatment and should be adapted to a patient’s specific needs, available resources, and any other unique circumstances. Neither the Sephardic Community Alliance, nor any contributor to this communication, makes any representations or warranties, express or implied, with respect to the information provided herein or to its use..